These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29930730)

  • 1. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
    Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
    Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
    Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
    Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
    Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
    PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineering of magnetic iron oxide nanoparticles by polymer grafting: synthesis progress and biomedical applications.
    Hou Z; Liu Y; Xu J; Zhu J
    Nanoscale; 2020 Jul; 12(28):14957-14975. PubMed ID: 32648868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles.
    Magro M; Baratella D; Bonaiuto E; de A Roger J; Vianello F
    Curr Med Chem; 2018 Feb; 25(4):540-555. PubMed ID: 28618993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.
    Pillarisetti S; Uthaman S; Huh KM; Koh YS; Lee S; Park IK
    Tissue Eng Regen Med; 2019 Oct; 16(5):451-465. PubMed ID: 31624701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics.
    Li K; Nejadnik H; Daldrup-Link HE
    Drug Discov Today; 2017 Sep; 22(9):1421-1429. PubMed ID: 28454771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold-based Inorganic Nanohybrids for Nanomedicine Applications.
    Ding X; Li D; Jiang J
    Theranostics; 2020; 10(18):8061-8079. PubMed ID: 32724458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic nanoparticles: A multifunctional vehicle for modern theranostics.
    Angelakeris M
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1642-1651. PubMed ID: 28219721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Nanoparticles in Cancer Theranostics.
    Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
    Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
    Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
    Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
    Hola K; Markova Z; Zoppellaro G; Tucek J; Zboril R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1162-76. PubMed ID: 25689073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rice starch coated iron oxide nanoparticles: A theranostic probe for photoacoustic imaging-guided photothermal cancer therapy.
    Vo TMT; Mondal S; Nguyen VT; Park S; Choi J; Bui NT; Oh J
    Int J Biol Macromol; 2021 Jul; 183():55-67. PubMed ID: 33857520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic iron oxide nanoparticles for biomedical applications.
    Laurent S; Bridot JL; Elst LV; Muller RN
    Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D Superparamagnetic Tantalum Carbide Composite MXenes for Efficient Breast-Cancer Theranostics.
    Liu Z; Lin H; Zhao M; Dai C; Zhang S; Peng W; Chen Y
    Theranostics; 2018; 8(6):1648-1664. PubMed ID: 29556347
    [No Abstract]   [Full Text] [Related]  

  • 19. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
    Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
    Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics.
    Tsai MF; Lo YL; Huang YC; Yu CC; Wu YT; Su CH; Wang LF
    Int J Nanomedicine; 2020; 15():8623-8639. PubMed ID: 33177822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.